Skip to main content

Table 6 Headache medications in migraine

From: A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan

Variables

Migrainea (N = 691)

n

%

Medication useb (past 6 months)

OTC and prescription drugsc

199

31.8

Prescription drugs only (acute and prophylactic)d

38

6.1

OTC drugs only

362

57.8

No prescription drugsd

27

4.3

Number of OTC analgesic types

1

403

58.3

2 or more

158

22.9

Types of prescription drugsd (prophylactic, past 6 months)

Total

56

8.1

Antidepressants

23

3.3

Anti-epileptics

13

1.9

Calcium channel blockers

11

1.6

ARB/ACE inhibitors

6

0.9

Beta-blocker

4

0.6

Others

6

0.9

Types of prescription drugsd (acute, past 6 months) 

Total

241

34.9

Acetaminophen/NSAIDs

206

29.8

Triptans

41

5.9

Antiemetics

28

4.1

Intravenous steroids

14

2.0

Tranquilizer/anesthetic preparations

6

0.9

Tramadol

1

0.1

Magnesium preparations

1

0.1

Ergotamine

0

0.0

Comorbidityd

(past 6 months)

Hypertension

51

7.4

Cardiovascular disorders

23

3.3

Cerebrovascular disorders

6

0.9

Gastrointestinal disorders

386

55.9

Constipation

50

7.2

Psychiatric/Psychosomatic disorders

104

15.1

Depression

48

6.9

Epilepsy

6

0.9

Asthma

51

7.4

Allergy

123

17.8

Autoimmune disorders

38

5.5

  1. Abbreviations: OTC Over-the-counter, ARC Angiotensin II receptor blocker, ACE Angiotensin converting enzyme, NSAID Non-Steroidal Anti-Inflammatory Drugs
  2. a Migraine included individuals classified as probable migraine
  3. b Denominator was the number who answered "yes" to a question of taking any drugs (n = 626)
  4. c Data used from questionnaire responses and the medical claims database
  5. d Data derived from the medical claims database